NO162562B - 3-ALFA, -7BETA-DIHYDROXY-12-KETO-5BETA-CHOLANIC ACID, AND THIS TRIS-TRIMETHYL DERIVATIVE. - Google Patents
3-ALFA, -7BETA-DIHYDROXY-12-KETO-5BETA-CHOLANIC ACID, AND THIS TRIS-TRIMETHYL DERIVATIVE. Download PDFInfo
- Publication number
- NO162562B NO162562B NO85853328A NO853328A NO162562B NO 162562 B NO162562 B NO 162562B NO 85853328 A NO85853328 A NO 85853328A NO 853328 A NO853328 A NO 853328A NO 162562 B NO162562 B NO 162562B
- Authority
- NO
- Norway
- Prior art keywords
- acid
- dihydroxy
- keto
- tris
- mixture
- Prior art date
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 229910007161 Si(CH3)3 Inorganic materials 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
- 239000000203 mixture Substances 0.000 description 19
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 11
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 11
- 229960001661 ursodiol Drugs 0.000 description 11
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 10
- 239000004380 Cholic acid Substances 0.000 description 10
- 229960002471 cholic acid Drugs 0.000 description 10
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 10
- 235000019416 cholic acid Nutrition 0.000 description 10
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229960002997 dehydrocholic acid Drugs 0.000 description 6
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- RHCPKKNRWFXMAT-UATRTCSUSA-N (4r)-4-[(3r,8r,9s,10s,12s,13r,14s,17r)-3,12-dihydroxy-10,13-dimethyl-7-oxo-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid Chemical compound C1C[C@@H](O)CC2CC(=O)[C@H]3[C@@H]4CC[C@H]([C@@H](CCC(O)=O)C)[C@@]4(C)[C@@H](O)C[C@@H]3[C@]21C RHCPKKNRWFXMAT-UATRTCSUSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- NDVMCQUOSYOQMZ-UHFFFAOYSA-N 2,2-bis(trimethylsilyl)acetamide Chemical compound C[Si](C)(C)C(C(N)=O)[Si](C)(C)C NDVMCQUOSYOQMZ-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 3
- 229960001091 chenodeoxycholic acid Drugs 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- MASDFXZJIDNRTR-UHFFFAOYSA-N 1,3-bis(trimethylsilyl)urea Chemical compound C[Si](C)(C)NC(=O)N[Si](C)(C)C MASDFXZJIDNRTR-UHFFFAOYSA-N 0.000 description 2
- 239000005708 Sodium hypochlorite Substances 0.000 description 2
- 238000005644 Wolff-Kishner reduction reaction Methods 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- -1 ester compounds Chemical class 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical class OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical class CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- 102100027324 2-hydroxyacyl-CoA lyase 1 Human genes 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- 101001009252 Homo sapiens 2-hydroxyacyl-CoA lyase 1 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Chemical class OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001801 chenodeoxycholic acids Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000001384 succinic acid Chemical class 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
Description
Denne oppfinnelse angår nye forbindelser, nemlig 3a, 7 (3-dihydroxy-12-keto-5|3-cholansyre og dens tris-trimethylsilylderivat, med den generelle formel: This invention relates to new compounds, namely 3a,7(3-dihydroxy-12-keto-5|3-cholanic acid and its tris-trimethylsilyl derivative, with the general formula:
hvor er hydrogen eller -SifCH^-j. Forbindelsene er egnede som mellomprodukter ved fremstilling av ursodeoxycholansyre ( 3a, 7|B-dihydroxycholansyre ) med høy renhet, som fremfor alt ikke er forurenset med chenodeoxycholsyreepimeren (3a,7a-dihydroxycholansyre). Fremstillingen av ursodeoxycholsyre ved hjelp av disse mellomprodukter er gjenstand for norsk patent nr. (norsk patentsøknad nr. 821194). where is hydrogen or -SifCH^-j. The compounds are suitable as intermediates in the production of ursodeoxycholic acid (3a, 7|B-dihydroxycholic acid) with high purity, which above all is not contaminated with the chenodeoxycholic acid epimer (3a,7a-dihydroxycholic acid). The production of ursodeoxycholic acid using these intermediates is the subject of Norwegian patent no. (Norwegian patent application no. 821194).
De fremgangsmåter som for tiden anvendes for fremstilling av ursodeoxycholsyre, faller alle i hovedsak innen-for det samme reaksjonsskjerna, som som hovedtrinn omfatter oxydasjon av chenodeoxycholsyre (A) til 3a-hydroxy-7-ketocholansyre (B), hvilken hydrogeneres til ursodeoxycholsyre (C) : The methods currently used for the production of ursodeoxycholic acid all essentially fall within the same reaction core, which as the main step comprises the oxidation of chenodeoxycholic acid (A) to 3a-hydroxy-7-ketocholic acid (B), which is hydrogenated to ursodeoxycholic acid (C ) :
Ulempen med de kjente fremgangsmåter som omfatter nevnte reaksjonsrekke, ligger i at reduksjonen av forbindelse B The disadvantage of the known methods which include the aforementioned reaction sequence is that the reduction of compound B
i samtlige tilfeller fører til en blanding av isomerer bestående av ca. 80 % av forbindelse C og 20 % av forbindelse A eller chenodeoxycholsyre, som det er vanskelig å fjerne. in all cases leads to a mixture of isomers consisting of approx. 80% of compound C and 20% of compound A or chenodeoxycholic acid, which is difficult to remove.
Alle de fremgangsmåter som hittil er blitt fore-slått for å separere blandingen av produkter A o'g C er kostbare når de skal utføres i industriell målestokk, og har begrenset virkningsgrad. All the methods that have been proposed so far to separate the mixture of products A and C are expensive when they are to be carried out on an industrial scale, and have a limited degree of efficiency.
Ved hjelp av den foreliggende oppfinnelse tilveie-bringes der nye forbindelser som muliggjør fremstilling av ursodeoxycholsyre direkte og med farmasøytisk renhet, spesielt med tanke på fravær av chenodeoxycholsyre, uten at det er nødvendig med påfølgende, kompliserte og kostbare renseprosesser. With the help of the present invention, new compounds are provided which enable the production of ursodeoxycholic acid directly and with pharmaceutical purity, especially in view of the absence of chenodeoxycholic acid, without the need for subsequent, complicated and expensive purification processes.
Ved den totalprosess hvor de nye forbindelser benyttes som mellomprodukter,benyttes cholsyre som utgangsmate-riale, men man kommer frem til ursodeoxycholsyre via en helt ny rekke av reaksjoner. In the overall process where the new compounds are used as intermediates, cholic acid is used as starting material, but ursodeoxycholic acid is arrived at via a completely new series of reactions.
I hovedsaken omfatter denne totalprosess de følgende trinn: 1. Selektiv oxydasj on av cholsyre eller 3<x, 7ot, 12cx— trihydroxycholansyre (I) til 3a, 12a-dihydroxy-7-ketocholansyre (II) etter kjente metoder (J.A.C.S. 71, 3935, 1949 - J.A..S. 72, 5530, 1950) Essentially, this total process comprises the following steps: 1. Selective oxidation of cholic acid or 3<x, 7ot, 12cx- trihydroxycholanic acid (I) to 3a, 12a-dihydroxy-7-ketocholanic acid (II) according to known methods (J.A.C.S. 71, 3935 , 1949 - J.A..S. 72, 5530, 1950)
Det nødvendige trinn for fremstilling av syren The necessary step for the production of the acid
(II) ut fra cholsyre, som lett kan skaffes på markedet, ut-føres etter kjente metoder som ovenfor angitt og utgjør derfor ingen del av oppfinnelsen. 2. Reduksjon av syren (II) til 3ot, 73, 12a-trihydroxycholansyre (III') ved behandling av en oppløsning av denne i en C1, -4„ alkohol med alkalimetaller (II) from cholic acid, which can be easily obtained on the market, is carried out according to known methods as indicated above and therefore forms no part of the invention. 2. Reduction of the acid (II) to 3ot, 73, 12a-trihydroxycholanic acid (III') by treating a solution of this in a C1, -4„ alcohol with alkali metals
Ved denne reaksjon dannes i virkeligheten syren (III') sammen med en begrenset mengde på mellom 10 og 15 % In this reaction, the acid (III') is actually formed together with a limited amount of between 10 and 15%
av den tilsvarende 7-a-isomer eller cholsyre (I). of the corresponding 7-a-isomer or cholic acid (I).
3a, 7&, 12a-trihydroxycholansyre(III' ) kan fåes i ren tilstand ved krystallisering fra egnede oppløsningsmid-ler eller gjennom fremstilling av produkter som er forestret helt eller delvis i stillingene 3, 7, 12 og 24, og rensning av de erholdte estere ved krystallisasjon fra egnede opp-løsningsmidler. Syren (III') frigjøres fra den således erholdte rene ester ved alkalisk forsåpning. 3a, 7&, 12a-trihydroxycholanic acid (III' ) can be obtained in a pure state by crystallization from suitable solvents or through the production of products that are esterified in whole or in part in positions 3, 7, 12 and 24, and purification of the obtained esters by crystallization from suitable solvents. The acid (III') is released from the thus obtained pure ester by alkaline saponification.
For formålet med oppfinnelsen er det imidlertid ikke nødvendig å oppnå ren syre (III'), og den anvendes i det neste trinn i totalsyntesen i den tilstand i hvilken den fåes, dvs. forurenset med cholsyre, men forestret på behørig måte med syre i stillingene 3 og 7 og eventuelt med en C^_^ alkohol i stilling 24. Disse forestringsreaksjoner kan, om nødvendig, utføres etter hverandre, idet de normale forestringsmetoder benyttes. Esterforbindelsene som fremstilles, har formelen: For the purposes of the invention, however, it is not necessary to obtain pure acid (III'), and it is used in the next step in the total synthesis in the state in which it is obtained, i.e. contaminated with cholic acid, but esterified in the appropriate manner with acid in the positions 3 and 7 and optionally with a C^_^ alcohol in position 24. These esterification reactions can, if necessary, be carried out one after the other, using the normal esterification methods. The ester compounds that are produced have the formula:
hvor R er en alifatisk syregruppe med 2-6 carbonatomer, usub-stituert eller substituert benzoesyre, ravsyre eller glutar-syre, og R' er hydrogen eller en alkylgruppe inneholdende 1-4 carbonatomer. 3. Oxydasjon av den forestrede 3a, 7|3, 12a-trihydroxy-5-|3-cholansyre (III) til den forestrede 3a, 7 |3-dihydroxy-12-keto-5|3-cholansyre med alkalisk hypokloritt i eddiksyre i henhold til ligningen: where R is an aliphatic acid group with 2-6 carbon atoms, unsubstituted or substituted benzoic acid, succinic acid or glutaric acid, and R' is hydrogen or an alkyl group containing 1-4 carbon atoms. 3. Oxidation of the esterified 3a, 7|3, 12a-trihydroxy-5-|3-cholanic acid (III) to the esterified 3a, 7|3-dihydroxy-12-keto-5|3-cholanic acid with alkaline hypochlorite in acetic acid according to the equation:
hvor R og R<1> har de ovenfor angitte betydninger. where R and R<1> have the meanings given above.
Overskuddet av hypokloritt ødelegges med bisulfitt. Fri 3a, 73-dihydroxy-12-keto-5|3-cholansyre fåes ved forsåpning med fortynnet sterkt alkali etterfulgt av sur-<g>jøring. The excess of hypochlorite is destroyed with bisulphite. Free 3a, 73-dihydroxy-12-keto-5|3-cholanic acid is obtained by saponification with dilute strong alkali followed by acidification.
Den således erholdte frie syre (IV-a; se nedenfor) inneholder forurensninger bestående hovedsakelig av 3a, 7a-dihydroxy-12-keto-5|3-cholansyre og uomsatt 3a, 7|3-trihydroxycholansyre. The thus obtained free acid (IV-a; see below) contains impurities consisting mainly of 3a, 7a-dihydroxy-12-keto-5|3-cholanic acid and unreacted 3a, 7|3-trihydroxycholanic acid.
4. Rensning av 3a, 7&-dihydroxy-12-keto-5f3-cholan-syren ved fremstilling av dens tris-trimethylsilylderivat gjennom behandling av syren, i oppløsning i et organisk oppløsningsmiddel, med et silaneringsmiddel, såsom bis-trimethylsilylurea, hexamethyldisilazan eller bis-trimethylsilylacetamid ved en temperatur mellom 30° og 100° C. 4. Purification of the 3α, 7β-dihydroxy-12-keto-5β3-cholanic acid in the preparation of its tris-trimethylsilyl derivative by treating the acid, in solution in an organic solvent, with a silanizing agent, such as bis-trimethylsilylurea, hexamethyldisilazane or bis -trimethylsilylacetamide at a temperature between 30° and 100° C.
I sammenheng hermed har det uventet vist seg at forbindelse (IV-b) har meget liten oppløselighet i organiske oppløsningsmidler, mens tris-trimethylsilylderivatene av forurensningene, og spesielt av 3a, 7a-dihydroxy-12-keto-5(3-cholansyre, er meget oppløselige i de samme oppløsnings-midler. 5. Eventuell fjerning av trimethylsilylgruppene ved sur hydrolyse, fortrinnsvis med HC1 i vandig oppløsning eller i et organisk oppløsningsmiddel i henhold til ligningen: 6. Reduksjon av 3a, 7P-dihydroxy-12-keto-53-cholansyre til ursodeoxycholsyre etter Wolff-Kishner-metoden, ved oppvarming til 200° C med hydrazinhydrat i nærvær av en alkalisk base og triethylenglycol: In connection with this, it has unexpectedly been shown that compound (IV-b) has very little solubility in organic solvents, while the tris-trimethylsilyl derivatives of the impurities, and especially of 3a, 7a-dihydroxy-12-keto-5(3-cholanic acid, are very soluble in the same solvents 5. Possible removal of the trimethylsilyl groups by acid hydrolysis, preferably with HC1 in aqueous solution or in an organic solvent according to the equation: 6. Reduction of 3a, 7P-dihydroxy-12-keto-53 -cholanic acid to ursodeoxycholic acid according to the Wolff-Kishner method, by heating to 200°C with hydrazine hydrate in the presence of an alkaline base and triethylene glycol:
En hydrolyse som den utført i trinn 5 kan eventuelt utføres etter en reduksjon som den utført i trinn 6, i den forstand at Wolff-Kishner-reduksjonen (trinn 6) kan utføres på tris-trimethylsilanderivatet og trimethylsilylgruppene elimineres fra den allerede reduserte forbindelse, dvs. fra tris-trimethylsilylderivatet av ursodeoxycholsyren av høy renhet. Trinn (6) og nevnte alternativ er gjenstand for norsk patent nr. (norsk patentsøknad nr. 821194). A hydrolysis like that carried out in step 5 can optionally be carried out after a reduction like that carried out in step 6, in the sense that the Wolff-Kishner reduction (step 6) can be carried out on the tris-trimethylsilane derivative and the trimethylsilyl groups are eliminated from the already reduced compound, i.e. .from the tris-trimethylsilyl derivative of the ursodeoxycholic acid of high purity. Step (6) and the aforementioned alternative are the subject of Norwegian patent no. (Norwegian patent application no. 821194).
De nye forbindelser med formel (IV) ifølge oppfinnelsen kan således fremstilles ut fra lett tilgjengelige utgangsmaterialer og kan overføres til ursodeoxycholsyre gjennom et begrenset antall trinn hvor det gjøres bruk av reaksjoner som kan utføres enkelt og med høy selektivitet. Ved bruk av de nye forbindelser som mellomprodukter fåes en ursodeoxycholsyre av farmasøytisk renhet, uten at det kreves påfølgende kompliserte og kostbare renseprosesser. The new compounds of formula (IV) according to the invention can thus be prepared from readily available starting materials and can be transferred to ursodeoxycholic acid through a limited number of steps using reactions that can be carried out easily and with high selectivity. By using the new compounds as intermediates, an ursodeoxycholic acid of pharmaceutical purity is obtained, without requiring subsequent complicated and expensive purification processes.
Overføringen av de nye forbindelser med formel (IV) til ursodeoxycholsyre med/høy renhet foretaes ved at en forbindelse med formel (IV) reduseres med hydrazinhydrat i nærvær av en alkalibase og triethylenglycol, og det erholdte produkt, dersom R^ = -Si(CH3)3, underkastes sur hydrolyse. The transfer of the new compounds of formula (IV) to ursodeoxycholic acid with/high purity is carried out by reducing a compound of formula (IV) with hydrazine hydrate in the presence of an alkali base and triethylene glycol, and the product obtained, if R^ = -Si(CH3 )3, is subjected to acid hydrolysis.
Denne fremstilling er nærmere beskrevet i norsk patent-skrift nr. (norsk patentsøknad nr. 821194), som det er henvist til i denne beskrivelses innledning. This preparation is described in more detail in Norwegian patent document no. (Norwegian patent application no. 821194), which is referred to in the introduction of this description.
De nedenstående eksempler illustrerer fremstillingen av de nye forbindelser med formel (IV). Først beskrives imidlertid fremstillingen av et par utgangsmaterialer med formel (III) som anvendes for fremstilling av forbindelsene med formel (IV). The following examples illustrate the preparation of the new compounds of formula (IV). First, however, the preparation of a pair of starting materials of formula (III) which are used for the preparation of the compounds of formula (IV) is described.
E??1§£iiiiD2_Ai_3i2l^i§2?£?£§5 _5Y_52fiZ£iI2a^ir^)}Yd^2x^9hoiani_ syre_£III2^E??1§£iiiiD2_Ai_3i2l^i§2?£?£§5 _5Y_52fiZ£iI2a^ir^)}Yd^2x^9hoiani_ acid_£III2^
100 g 3a,12a-dihydroxy-7-ketocholansyre (II) erholdt ved selektiv oxydasjon av cholsyre (I) (i henhold til J.A.C.S. 71, 3935/1949; J.A.C.S. 72, 5530/1950) ble oppløst i 2000 100 g of 3α,12α-dihydroxy-7-ketocholic acid (II) obtained by selective oxidation of cholic acid (I) (according to J.A.C.S. 71, 3935/1949; J.A.C.S. 72, 5530/1950) was dissolved in 2000
ml sekundær butylalkohol. Oppløsningen ble oppvarmet til kokning, og 100 g metallisk natrium ble tilsatt. Kokningen ble foretatt i 2 timer under tilbakeløpsbetingelser, hvoretter ml of secondary butyl alcohol. The solution was heated to boiling and 100 g of metallic sodium was added. Boiling was carried out for 2 hours under reflux conditions, after which
butylalkoholen ble avdestillert under samtidig tilførsel av en like stor mengde vann. Da all butylalkohol var blitt fjer-net , ble blandingen avkjlt og surgjort med 20%-ig HC1. Den erholdte utfeining ble frafiltrert, vasket med vann og tørket, hvorved det ble erholdt 95 g av et tørt, amorft produkt som ved HPLC-analyse viste seg å bestå av 88,9% 3a, 73,12oc-trihydroxycholansyre og 9,2% cholsyre. the butyl alcohol was distilled off with the simultaneous addition of an equal amount of water. When all the butyl alcohol had been removed, the mixture was cooled and acidified with 20% HCl. The resulting slurry was filtered off, washed with water and dried, whereby 95 g of a dry, amorphous product was obtained which, by HPLC analysis, was found to consist of 88.9% 3a, 73.12oc-trihydroxycholanic acid and 9.2% cholic acid.
Acidimetrisk titer = 99,1%. Acidimetric titer = 99.1%.
[a]p° = +71,2° (C = 1% i dioxan). [a]p° = +71.2° (C = 1% in dioxane).
200 ml benzen, 50 ml pyridin og 50 ml eddiksyreanhydrid ble satt til 50 g av den med cholsyre forurensede 3a,73,12a-trihydroxycholansyre. Blandingen ble tillatt å reagere i 48 timer ved 20-25°C, hvoretter det ble tilsatt 50 ml vann under omrøring og deretter, noen få minutter senere, en blanding av 200 ml vann og 60 ml 37%-ig HC1. Den vandige fase ble fjer-net, og den organiske fase ble inndampet nesten til tørrhet, hvoretter det ble erholdt et residuum inneholdende 3,7-diacetatet av 3a, 73,12a-trihydroxycholansyre . 200 ml of benzene, 50 ml of pyridine and 50 ml of acetic anhydride were added to 50 g of the cholic acid-contaminated 3α,73,12α-trihydroxycholanic acid. The mixture was allowed to react for 48 hours at 20-25°C, after which 50 ml of water was added with stirring and then, a few minutes later, a mixture of 200 ml of water and 60 ml of 37% HCl. The aqueous phase was removed, and the organic phase was evaporated almost to dryness, after which a residue containing the 3,7-diacetate of 3a,73,12a-trihydroxycholanic acid was obtained.
Fremstilling_B£_3i7-disuccinatet_av_3 a.j.7 3^12a-trihydroxycholansyre_ (^III|. Preparation_B£_3i7-disuccinate_of_3 a.j.7 3^12a-trihydroxycholanic acid_ (^III|.
100 g metallisk kalium ble tilsatt under kokning til 100 g 3a,12a-dihydroxy-7-ketocholansyre (II) oppløst i 2000 ml n-butylalkohol, og blandingen ble oppvarmet under tilbake-løpsbetingelser i 2 timer. Deretter ble all butylalkohol avdestillert, mens det samtidig ble tilsatt vann. Etter endt destillasjon ble blandingen surgjort med 20%-ig HC1, og det utfelte faste stoff ble frafiltrert. 100 g of metallic potassium was added under boiling to 100 g of 3α,12α-dihydroxy-7-ketocholanic acid (II) dissolved in 2000 ml of n-butyl alcohol, and the mixture was heated under reflux conditions for 2 hours. All butyl alcohol was then distilled off, while water was added at the same time. After the end of the distillation, the mixture was acidified with 20% HCl, and the precipitated solid was filtered off.
Da det faste stoff (95 g) ble underkastet HPCL-analyse, viste det seg å bestå av 90% 3a, 7(3,12 a-trihydroxycholansyre og 10% cholsyre. Blandingens karakteristiske egenskaper svarte til dem ifølge Eksempel 1. When the solid (95 g) was subjected to HPCL analysis, it was found to consist of 90% 3a,7(3,12a-trihydroxycholanic acid and 10% cholic acid. The characteristic properties of the mixture corresponded to those according to Example 1.
100 g av en blanding av 3a,73,12a-trihydroxycholansyre og cholsyren erholdt i det foregående trinn ble oppløst i 150 ml pyridin. Det ble tilsatt 100 g ravsyreanhydrid, og blandingen ble oppvarmet ved 80°C i 5 timer. Blandingen ble så kjølt til 0°C, og 100 ml vann ble tilsatt. Blandingen ble tillatt å stå under omrøring i 2 timer. Det ble tilsatt 1000 100 g of a mixture of 3a,73,12a-trihydroxycholanic acid and the cholic acid obtained in the previous step were dissolved in 150 ml of pyridine. 100 g of succinic anhydride was added, and the mixture was heated at 80°C for 5 hours. The mixture was then cooled to 0°C and 100 ml of water was added. The mixture was allowed to stand under stirring for 2 hours. 1000 was added
ml ethylacetat, og pH-verdien ble innstilt på 3-3,5 med HC1. Den vandige fase ble fraskilt. Den tilbakeblivende organiske oppløsning inneholdt det ønskede 3 , 7-disuccinat av 3a, 7|3,12 a-trihydroxycholansyre. ml of ethyl acetate, and the pH was adjusted to 3-3.5 with HCl. The aqueous phase was separated. The remaining organic solution contained the desired 3,7-disuccinate of 3a,7|3,12a-trihydroxycholanic acid.
Eksempel 1 Example 1
Fremstilling av 3a, 73- dihydroxy- 12- ketocholansyre ( IV- a) og dennes 3a, 73- bis- trimethoxysilylether- 24- trimethylsilyles- Preparation of 3a,73-dihydroxy-12-ketocholanic acid (IV-a) and its 3a,73-bistrimethoxysilylether-24-trimethylsilyles-
ter ( IV- b) ter (IV-b)
Residuet inneholdende 3 , 7-diacetatet av 3a, 7|3,12a-trihydroxycholansyre, som ble erholdt under Fremstilling A ovenfor, ble tatt opp i 500 ml ethylacetet, til hvilket det var tilsatt 30 ml 80% eddiksyre og 15% natriumhypokloritt. Blandingen ble omrørt i 1 time, overskuddet av hypokloritt ble ødelagt med natriummetabisulfitt, og ethylacetatet ble vasket med 500 ml vann. Den organiske fase ble inndampet til tørrhet og ble kokt med 200 ml 10%-ig NaOH i 5 timer. Det ble surgjort med HC1 og ekstrahert med ethylacetat. 45 g residuum ble opp-nådd ut fra den organiske fase ved inndampning og denne til tørrhet. Ved HPLC-analyse viste produktet seg å bestå av: The residue containing the 3,7-diacetate of 3a,7|3,12a-trihydroxycholanic acid, which was obtained in Preparation A above, was taken up in 500 ml of ethyl acetate, to which was added 30 ml of 80% acetic acid and 15% sodium hypochlorite. The mixture was stirred for 1 hour, the excess of hypochlorite was destroyed with sodium metabisulfite, and the ethyl acetate was washed with 500 ml of water. The organic phase was evaporated to dryness and boiled with 200 ml of 10% NaOH for 5 hours. It was acidified with HCl and extracted with ethyl acetate. 45 g of residue was obtained from the organic phase by evaporation and this to dryness. By HPLC analysis, the product was found to consist of:
- 75% 3a, 7|3-dihydroxy-12-ketocholansyre - 75% 3a, 7|3-dihydroxy-12-ketocholanic acid
8% 3a,7a-dihydroxy-12-ketocholansyre 8% 3α,7α-dihydroxy-12-ketocholanic acid
- 15% 3a, 7(J, 12a-trihydroxycholansyre - 15% 3a, 7(J, 12a-trihydroxycholanic acid
2% cholsyre. 2% cholic acid.
50 g urent produkt erholdt i det foregående trinn ble oppløst i 500 ml N,N-dimethylformamid. Det ble tilsatt 50 50 g of impure product obtained in the previous step was dissolved in 500 ml of N,N-dimethylformamide. 50 was added
g bis-trimethylsilylurea, og blandingen ble oppvarmet til 100°C og holdt ved denne temperatur i 1 time under omrøring, hvoretter den ble avkjølt. 3a,73-bis-trimethylsilylether-24-tri-methylsilylesteren ble frafiltrert og vasket med 50 ml N,N-di-methylf ormamid. Produktet ble så tørret i en ovn ved 70°C g of bis-trimethylsilylurea, and the mixture was heated to 100°C and held at this temperature for 1 hour with stirring, after which it was cooled. The 3α,73-bis-trimethylsilyl ether-24-trimethylsilyl ester was filtered off and washed with 50 ml of N,N-dimethylformamide. The product was then dried in an oven at 70°C
under vakuum. Det ble erholdt 60 g produkt med de følgende karakteristika: under vacuum. 60 g of product with the following characteristics were obtained:
Molvekt: 62 3,13 Molecular weight: 62 3.13
Smeltepunkt = 155-157°C Melting point = 155-157°C
[a]^°= +89° (C = 2% i dioxan). [a]^°= +89° (C = 2% in dioxane).
Eksempel 2 Example 2
Fremstilling av 3a, 7ft- dihydroxy- 12- ketocholansyre ( IV- a) og dennes 3a, 7[ 3- bis- trimethylsilylether- 2 4- trimethylsilyles- Preparation of 3a, 7ft- dihydroxy- 12- ketocholanic acid ( IV- a) and its 3a, 7[ 3- bis- trimethylsilyl ether- 2 4- trimethylsilyles-
ter ( IV- b) ter (IV-b)
50 ml eddiksyre og 50 ml av en 10%-ig vandig oppløsning av KBr ble tilsatt den under Fremstilling B erholdte organiske oppløsning, og temperaturen ble innstilt på 20°C. Mens denne temperatur ble opprettholdt, ble det tilsatt 150 ml av en 15%-ig oppløsning av natriumhypokloritt. Blandingen ble tillatt å stå under omrøring i 30 minutter, hvoretter produktet ble frafiltrert, vasket med 200 ml ethylacetat og tørket i en ovn ved 80°C. Det tørre produkt ble kokt i 2 timer med 1000 ml 10%-ig NaOH. Blandingen ble så kjølt, hvoretter det ble tilsatt 1000 ml ethylacetat og blandingen ble surgjort med 20%-ig HC1. Den organiske fase ble fraskilt og inndampet til et volum på ca. 300 ml. Det ble foretatt avkjøling til 0°C 50 ml of acetic acid and 50 ml of a 10% aqueous solution of KBr were added to the organic solution obtained during Preparation B, and the temperature was set to 20°C. While maintaining this temperature, 150 ml of a 15% solution of sodium hypochlorite was added. The mixture was allowed to stand under stirring for 30 minutes, after which the product was filtered off, washed with 200 ml of ethyl acetate and dried in an oven at 80°C. The dry product was boiled for 2 hours with 1000 ml of 10% NaOH. The mixture was then cooled, after which 1000 ml of ethyl acetate was added and the mixture was acidified with 20% HCl. The organic phase was separated and evaporated to a volume of approx. 300 ml. Cooling to 0°C was carried out
og filtrering. Produktet ble vasket med 100 ml ethylacetat og tørket i en ovn ved 80°C. Det ble erholdt 70 g uren, 3a, 7|3-dihydroxy-12-ketocholansyre. and filtering. The product was washed with 100 ml of ethyl acetate and dried in an oven at 80°C. 70 g of impure, 3a, 7|3-dihydroxy-12-ketocholanic acid were obtained.
100 ml acetonitril, 700 ml hexamethyldisilazan og 300 ml trimethylklorsilan ble satt til 100 g uren 3a,73-dihydroxy-12-ketocholansyre erholdt i det foregående trinn. Blandingen ble oppvarmet under tilbakeløpsbetingelser i 1 time, hvoretter den ble avkjølt. 3a, 7 |3-bis-trimethylsilylether-2 4-t ri-methylsilylesteren som utkrystalliserte, ble frafiltrert, vasket med acetonitril og tørket ved 60°C under vakuum. 100 ml of acetonitrile, 700 ml of hexamethyldisilazane and 300 ml of trimethylchlorosilane were added to 100 g of impure 3α,73-dihydroxy-12-ketocholanic acid obtained in the previous step. The mixture was heated under reflux conditions for 1 hour, after which it was cooled. The 3a, 7|3-bis-trimethylsilyl ether-2 4-t trimethylsilyl ester which crystallized was filtered off, washed with acetonitrile and dried at 60°C under vacuum.
50 g av det således erholdte tris-trimethylsilylderivat ble oppløst under omrøring og i løpet av 10 minutter i 500 50 g of the thus obtained tris-trimethylsilyl derivative was dissolved with stirring and during 10 minutes in 500
ml ethylacetat og 100 ml 10%-ig HC1 ved en temperatur på 50°C. Den organiske fase ble fraskilt og vasket med 100 ml 10%-ig HC1 ved 50°C i 10 minutter. Den organiske fase ble fraskilt og vasket med 100 ml vann. Ved konsentrering utkrystalliserte meget ren 3a,73-dihydroxy-12-keto-53-cholansyre. Denne ble frafiltrert, vasket med ethylacetat og tørket i en ovn ved 80°C. ml of ethyl acetate and 100 ml of 10% HCl at a temperature of 50°C. The organic phase was separated and washed with 100 ml of 10% HCl at 50°C for 10 minutes. The organic phase was separated and washed with 100 ml of water. Upon concentration, very pure 3α,73-dihydroxy-12-keto-53-cholanic acid crystallized. This was filtered off, washed with ethyl acetate and dried in an oven at 80°C.
Karakteristika: Characteristics:
Molvekt = 406,5 Molar weight = 406.5
Smeltepunkt = 190°C Melting point = 190°C
[a]p°= +108° - 3 (C = 1% i dioxan) [a]p°= +108° - 3 (C = 1% in dioxane)
Totalmengde forurensninger, bestemt ved kromatografering 0,5%. Total amount of impurities, determined by chromatography 0.5%.
Eksempel 3 Example 3
Fremgangsmåten beskrevet i Eksempel 1 ble gjentatt The procedure described in Example 1 was repeated
på nøyaktig samme måte, unntatt for trinnet hvor tris-trimethylsilylderivatet ble fremstilt, hvilket trinn ble utført som følger: 50 ml bis-trimethylsilylacetamid ble satt til 50 g uren 3a, 7 |3-dihydroxy-12-ketocholansyre oppløst i 500 ml N,N-dimethylformamid. Blandingen ble oppvarmet til 100°C, holdt ved denne temperatur i 1 time under omrøring og deretter av-kjølt. Utfelningen ble frafiltrert og omkrystallisert fra N,N-dimethylformamid i nærvær av 10 ml bis-trimethylsilylacetamid ved 100°C i 1 time. Produktet ble frafiltrert, vasket og tørret ved 70°C under vakuum. Det ble erholdt 61 g av tris-trimethylsilylderivatet av 3a, 7|3-dihydroxy-12-ketocholansyre. Produktet hadde de i Eksempel 1 angitte karakteristika. in exactly the same way, except for the step where the tris-trimethylsilyl derivative was prepared, which step was carried out as follows: 50 ml of bis-trimethylsilylacetamide was added to 50 g of impure 3a, 7 |3-dihydroxy-12-ketocholic acid dissolved in 500 ml of N, N-dimethylformamide. The mixture was heated to 100°C, held at this temperature for 1 hour with stirring and then cooled. The precipitate was filtered off and recrystallized from N,N-dimethylformamide in the presence of 10 ml of bis-trimethylsilylacetamide at 100°C for 1 hour. The product was filtered off, washed and dried at 70°C under vacuum. 61 g of the tris-trimethylsilyl derivative of 3a,7|3-dihydroxy-12-ketocholanic acid were obtained. The product had the characteristics stated in Example 1.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO853328A NO162562C (en) | 1981-04-14 | 1985-08-23 | 3-ALFA, -7BETA-DIHYDROXY-12-KETO-5BETA-CHOLANIC ACID, AND THIS TRIS-TRIMETHYL SILILINE DERIVATIVE. |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT21137/81A IT1137459B (en) | 1981-04-14 | 1981-04-14 | PRODUCTION FOR THE PREPARATION OF HIGH PURITY URSODEOXICOLIC ACID |
NO821194A NO162665C (en) | 1981-04-14 | 1982-04-13 | PROCEDURE FOR THE PREPARATION OF HIGH PURITY OF ORDEXOXYCHOLIC ACID. |
NO853328A NO162562C (en) | 1981-04-14 | 1985-08-23 | 3-ALFA, -7BETA-DIHYDROXY-12-KETO-5BETA-CHOLANIC ACID, AND THIS TRIS-TRIMETHYL SILILINE DERIVATIVE. |
Publications (3)
Publication Number | Publication Date |
---|---|
NO853328L NO853328L (en) | 1982-10-15 |
NO162562B true NO162562B (en) | 1989-10-09 |
NO162562C NO162562C (en) | 1990-01-17 |
Family
ID=27273139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO853328A NO162562C (en) | 1981-04-14 | 1985-08-23 | 3-ALFA, -7BETA-DIHYDROXY-12-KETO-5BETA-CHOLANIC ACID, AND THIS TRIS-TRIMETHYL SILILINE DERIVATIVE. |
Country Status (1)
Country | Link |
---|---|
NO (1) | NO162562C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE39678E1 (en) * | 1998-05-13 | 2007-06-05 | Novo Nordisk A/S | Meiosis regulating compounds |
-
1985
- 1985-08-23 NO NO853328A patent/NO162562C/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE39678E1 (en) * | 1998-05-13 | 2007-06-05 | Novo Nordisk A/S | Meiosis regulating compounds |
Also Published As
Publication number | Publication date |
---|---|
NO162562C (en) | 1990-01-17 |
NO853328L (en) | 1982-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU1771476C (en) | Method for production of 1,6-dichlorine-1,6-didesoxy-@@@-d-fruclofuranosyl-4-chloro-4 desoxy-@@@-d-galactopyranoside | |
NO162665B (en) | PROCEDURE FOR THE PREPARATION OF HIGH PURITY OF ORDEXOXYCHOLIC ACID. | |
NO140977B (en) | ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-AMINO-1,4-DIHYDROPYRIDINES | |
US4284797A (en) | Process for separating mixtures of 3- and 4-nitrophthalic acid | |
NO162562B (en) | 3-ALFA, -7BETA-DIHYDROXY-12-KETO-5BETA-CHOLANIC ACID, AND THIS TRIS-TRIMETHYL DERIVATIVE. | |
US3133940A (en) | Process for the separation of delta-1, 4-3-keto steroid compounds from mixtures thereof with other 3-keto steroids | |
JPS6254316B2 (en) | ||
JPS5850240B2 (en) | Production method for new androstane-based diene derivatives | |
US4173648A (en) | 3β-Hydroxy-18β-olean-9-en-30-oic acids | |
NO149353B (en) | PROCEDURE FOR PREPARING 6-CHLORO-ALFA-METHYL CARBZOL-2-ACETIC ACID | |
EP0390496B1 (en) | Intermediates useful for the synthesis of delphinidin chloride | |
KR870001937B1 (en) | Process for preparing(3-keto omega 4 or omega 1,4)-7-substituted steroid derivatives | |
JPH0411557B2 (en) | ||
NO312593B1 (en) | Process for preparing a deoxyuridine derivative | |
JPH0522709B2 (en) | ||
JPS6053039B2 (en) | N-Acetyl/Iramic acid derivative and method for producing the same | |
US4083850A (en) | 3-Substituted-2(1H)pyridon-6-carboxylic acids and process for preparation of same | |
NO750877L (en) | ||
EP0054370B1 (en) | Process for the manufacture of 3,6-dialkyl resorcylic acid esters | |
US4156728A (en) | 3-Substituted-2(1H)pyridone-6-carboxylic acids | |
KR100249554B1 (en) | Novel 6-substituted steroids, methods for producing same and pharmaceutical compositions containing said steroids | |
US3798212A (en) | Resolution of benzodiazepine derivatives | |
SU278684A1 (en) | METHOD OF OBTAINING N-A1I, HJIAMHAA ALIPHATIC OR AROMATIC SERIES | |
JPS6287599A (en) | Production of oxime derivative of erythromycin | |
SU622403A3 (en) | Method of producing dibenzooxepine |